Abstract:A dysregulated immune response toward self-antigens characterizes autoimmune and autoinflammatory (AIF) disorders. Autoantibodies or autoreactive T cells contribute to autoimmune diseases, while autoinflammation results from a hyper-functional innate immune system. Aside from their differences, many studies suggest that monocytes and macrophages (Mo/Ma) significantly contribute to the development of both types of disease. Mo/Ma are innate immune cells that promote an immune-modulatory, pro-inflammatory, or repair response depending on the microenvironment. However, understanding the contribution of these cells to different immune disorders has been difficult due to their high functional and phenotypic plasticity. Several factors can influence the function of Mo/Ma under the landscape of autoimmune/autoinflammatory diseases, such as genetic predisposition, epigenetic changes, or infections. For instance, some vaccines and microorganisms can induce epigenetic changes in Mo/Ma, modifying their functional responses. This phenomenon is known as trained immunity. Trained immunity can be mediated by Mo/Ma and NK cells independently of T and B cell function. It is defined as the altered innate immune response to the same or different microorganisms during a second encounter. The improvement in cell function is related to epigenetic and metabolic changes that modify gene expression. Although the benefits of immune training have been highlighted in a vaccination context, the effects of this type of immune response on autoimmunity and chronic inflammation still remain controversial. Induction of trained immunity reprograms cellular metabolism in hematopoietic stem cells (HSCs), transmitting a memory-like phenotype to the cells. Thus, trained Mo/Ma derived from HSCs typically present a metabolic shift toward glycolysis, which leads to the modification of the chromatin architecture. During trained immunity, the epigenetic changes facilitate the specific gene expression after secondary challenge with other stimuli. Consequently, the enhanced pro-inflammatory response could contribute to developing or maintaining autoimmune/autoinflammatory diseases. However, the prediction of the outcome is not simple, and other studies propose that trained immunity can induce a beneficial response both in AIF and autoimmune conditions by inducing anti-inflammatory responses. This article describes the metabolic and epigenetic mechanisms involved in trained immunity that affect Mo/Ma, contraposing the controversial evidence on how it may impact autoimmune/autoinflammation conditions.

Trained immunity-based vaccines for infections and allergic diseases

From trained immunity in allergy to trained immunity‐based allergen vaccines

Trained innate immunity: concept, nomenclature and future perspectives

Trained immunity: adaptation within innate immune mechanisms.

Trained immunity: General and emerging concepts

Molecular and Cellular Mechanisms Modulating Trained Immunity by Various Cell Types in Response to Pathogen Encounter

Trained Immunity as an Adaptive Branch of Innate Immunity

Innate Immune Memory Of Tissue-Resident Macrophages And Trained Innate Immunity: Re-Vamping Vaccine Concept And Strategies

Trained immunity in type 2 immune responses

Defining trained immunity and its role in health and disease

Trained immunity-inducing vaccines: Harnessing innate memory for vaccine design and delivery

The causes and consequences of trained immunity in myeloid cells

Therapeutic targeting of trained immunity

Trained Immunity Contribution to Autoimmune and Inflammatory Disorders

Trained immunity as a novel approach against COVID‐19 with a focus on Bacillus Calmette–Guérin vaccine: mechanisms, challenges and perspectives

Trained Immunity: an Overview and the Impact on COVID-19

Probiotics and Trained Immunity

Trained innate immunity, epigenetics, and food allergy

Innate immune memory, trained immunity and nomenclature clarification

Navigating the crossroads: asthma, trained immunity, and infection susceptibility

Trained immunity and inflammation in rheumatic diseases